Sign in

You're signed outSign in or to get full access.

Jair Clarke

Director at Xponential Fitness
Board

About Jair Clarke

Independent Class II director at Xponential Fitness since July 2022; age 43. Technology executive with >15 years across product management, digital transformation, cybersecurity, data science, and innovation. Currently CEO and Chief Artificial Intelligence Officer at Laigic.com (joined 2024) and a director at OneMedNet (clinical imaging software). Holds a B.B.A. in Computer Information Systems from the University of Miami . He is an independent NYSE-qualified director at XPOF and serves on multiple board committees, including as chair of Human Capital Management .

Past Roles

OrganizationRoleTenureCommittees/Impact
MicrosoftGlobal CTO, Commercial SystemsJoined Aug 2020; previously served before joining Laigic in 2024Senior technology leadership at scale
The Walt Disney CompanyVarious technology and business executive positions2014–2020Digital transformation and operations roles
IBMIT & Business Development Executive2007–2014Enterprise IT and BD experience
Lockheed MartinExpanding technology responsibilities2005–2007Engineering/IT exposure

External Roles

OrganizationRoleTenureCommittees/Impact
Laigic.com (advisory/consulting)CEO & Chief Artificial Intelligence Officer2024–presentAI leadership; private firm (governance not disclosed in proxy)
OneMedNet (healthcare software)DirectorNot disclosedClinical imaging solutions; no interlocks with XPOF disclosed

Board Governance

  • Independence: Determined independent under NYSE rules; no family relationships disclosed. Board currently has seven members; roles of Chair and CEO are separated .
  • Committee assignments (2024 activity year):
    • Human Capital Management Committee: Chair (approves/oversees executive and director pay; administers equity plans) .
    • Audit Committee: Member; committee is fully independent; all members financially literate (audit financial expert designation applies to other members) .
    • Nominating & Corporate Governance Committee: Member .
  • Attendance and engagement: In 2024 there were 24 board meetings; each director attended at least 75% of board and committee meetings; all directors attended the 2024 annual meeting .
  • Risk and controls: Audit Committee oversees financial and cybersecurity risk and reviews related party transactions; HCM Committee assesses pay-related risk; Nominating Committee oversees governance guidelines .

Fixed Compensation

YearFees Earned or Paid in Cash ($)Notes
202398,515Under May 10, 2023 Outside Director Compensation Policy
2024117,050Under updated July 1, 2024 Policy

Policy fee schedule as of July 1, 2024 (relevant to Clarke’s roles):

  • Board member: $80,000 annual cash retainer
  • Audit Committee member: $12,000
  • Human Capital Management Committee chair: $15,000
  • Nominating & Corporate Governance Committee member: $8,000
  • Non-cash option: directors may elect RSUs in lieu of cash for all/part of retainers

Performance Compensation

Grant DateInstrumentQuantityGrant-Date Fair Value ($)VestingNotes
May 30, 2024RSUs9,88892,453Eligible to vest May 21, 2025, service-basedAnnual director equity grant; time-based, not performance-vested
  • Directors can elect fully vested RSUs in lieu of cash retainers; in 2024 this election was disclosed for Mark Grabowski and Jeffrey Lawrence, not for Clarke .
  • Omnibus Incentive Plan applies to non-employee directors; upon a change in control, the committee may continue/assume, substitute, accelerate, or cash-out awards, including determining performance attainment for performance awards (director equity grants are time-based) .

Other Directorships & Interlocks

CompanyPublic/PrivateRolePotential Interlock/Conflict
OneMedNetNot specified in proxyDirectorNo related-party transactions with XPOF disclosed
Laigic.comPrivateCEO & Chief AI OfficerNo related-party transactions with XPOF disclosed
  • Related-person transaction oversight: XPOF’s Audit Committee administers a formal Related Person Transaction Policy for items over $120,000; only transactions described in the proxy would qualify, and none involve Clarke .

Expertise & Qualifications

  • Deep technology and AI background (Microsoft CTO role; AI leadership at Laigic) aligned with XPOF’s growing digital and data needs .
  • Governance experience across multiple large enterprises (Disney, IBM) and as a public company director (XPOF and OneMedNet) .
  • Financial literacy via Audit Committee service; committee meets NYSE and SEC independence and literacy standards .
  • Independent status and multi-committee workload (chairing HCM) indicate high governance engagement .

Equity Ownership

As of March 31, 2025Amount% of Class
Total beneficial ownership (Class A)16,606<1%
Ownership breakdown6,718 shares held directly; 9,888 RSUs vesting within 60 days
Pledged sharesNone disclosed for Clarke in ownership footnotes
Anti-hedgingDirectors prohibited from hedging company stock

Director Compensation – Year-over-Year Mix

YearCash ($)Stock Awards ($)Total ($)
202398,51524,079122,594
2024117,05092,453209,503
  • Mix shifted toward equity in 2024 following policy update (annual equity value increased to $110,000 and service-based RSUs granted), which can improve alignment but lacks performance conditions at the director level .

Governance Assessment

  • Positives

    • Independent director with strong technology/AI credentials; multi-committee service including HCM chair enhances board effectiveness on compensation oversight and talent strategy .
    • Audit Committee service supports financial oversight; committee independence and literacy standards met .
    • Attendance adequate: at least 75% of applicable meetings in 2024; full board attendance at 2024 annual meeting .
    • Anti-hedging policy applies to directors; no share pledging disclosed for Clarke, reducing alignment risk .
  • Watch items

    • Director equity is time-based RSUs (no performance-vesting), which aligns ownership but does not directly tie director pay to TSR or operational results; investors may prefer performance-linked elements for executives (less common for directors) .
    • The board remains classified (staggered terms), which some governance frameworks view as entrenching; though not specific to Clarke, it affects overall board accountability .
    • 2024 financial statement restatement did not trigger clawback recovery; as HCM chair, continued monitoring of compensation risk and clawback policy effectiveness remains important for investor confidence .
  • Red flags

    • None specific to Clarke disclosed: no related-party transactions, no Section 16 filing delinquencies for Clarke in 2024 .

Board Governance (Committee Map for Clarke)

CommitteeRoleKey Oversight Areas
Human Capital ManagementChairExecutive and director compensation; equity plan administration; pay philosophy and incentive plans
AuditMemberAuditor oversight; internal controls; financial/cyber risk; related-party transaction review
Nominating & Corporate GovernanceMemberBoard composition and evaluations; governance policies; code waivers

Notes on Policies Relevant to Clarke

  • Outside Director Compensation Policy (as of July 1, 2024): cash retainers by role; equity grant $110,000; optional RSUs in lieu of cash .
  • Omnibus Incentive Plan: applicable to non-employee directors; provides pathways for award treatment upon change in control (including possible acceleration) .
  • Related Person Transaction Policy: Audit Committee reviews/approves related-party transactions; no Clarke-related items disclosed .
  • Anti-hedging: prohibits directors from hedging XPOF equity; supports alignment .